The image depicts the structure of the Ebola virus surface glycoprotein (the protein targeted by the antibody cocktail ZMAb). (Image Credit: Jonathan Audet)
Researchers at the Public Health Agency of Canada have studied how the experimental Ebola-treating antibody cocktail ZMAb – a major constituent of the drug ZMApp – fights the virus. They report that the drug binds to the proteins on the surface of the virus and neutralises its activity. The researchers say the findings may help in the design of other treatments against Ebola virus infection.
More resources for journalists covering Ebola
Our backgrounder Preparing for Ebola.
Special collection: The Ebola epidemic
Because of the current outbreak, Science and Science Translational Medicine is making their research and news articles on Ebola freely available.
When you want to catch up quickly with the coverage, Ebola Deeply is an independent digital media project led by journalists and technologists. The project is funded in part by the World Economic Forum, Columbia University’s Graduate School of Journalism and the Baker Institute at Rice University.
